ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 676

$667K Total Retail Price of All Prescriptions

Rank: 137 out of 676

416 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 13,165 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 548 525 1 3
POTASSIUM CHLORIDE 543 482 2 9
OMEPRAZOLE 522 465 3 2
PRAVASTATIN SODIUM 502 425 4 11
LEVOTHYROXINE SODIUM 381 355 5 7
METOPROLOL TARTRATE 362 313 6 22
FUROSEMIDE 329 294 7 4
WARFARIN SODIUM 324 292 8 18
HYDROCHLOROTHIAZIDE 320 281 9 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 308 243 10 16
CRESTOR 304 241 11 29
METFORMIN HCL 251 210 12 8
GABAPENTIN 245 240 13 10
LISINOPRIL 214 192 14 5
SIMVASTATIN 209 196 15 6
DICLOFENAC POTASSIUM 198 192 16 199
SYNTHROID 192 192 17 48
CARVEDILOL 185 156 18 15
NEXIUM 175 149 19 23
LOSARTAN POTASSIUM 173 164 20 34
ATENOLOL 160 143 21 25
RANITIDINE HCL 158 125 22 27
PANTOPRAZOLE SODIUM 156 138 23 42
ZOLPIDEM TARTRATE 153 128 24 21
ISOSORBIDE MONONITRATE ER 151 128 25 54
GLIMEPIRIDE 139 121 26 30
LABETALOL HCL 138 120 27 285
NIFEDIPINE ER 136 100 28 100
MELOXICAM 130 120 29 13
CLOPIDOGREL 120 92 30 28
DIOVAN HCT 117 116 31 41
AMLODIPINE BESYLATE-BENAZEPRIL 112 106 32 44
ALLOPURINOL 110 89 33 31
PLAVIX 109 91 34 40
SERTRALINE HCL 105 105 35 26
DONEPEZIL HCL 105 105 35 24
DIOVAN 105 96 35 37
DIGOXIN 98 97 38 52
METOPROLOL SUCCINATE 98 78 38 14
LOVASTATIN 94 83 40 33
CLONIDINE HCL 91 67 41 32
TAMSULOSIN HCL 86 64 42 38
MEGESTROL ACETATE 78 78 R 43 111
BYSTOLIC 77 77 44 96
LOSARTAN-HYDROCHLOROTHIAZIDE 75 74 45 51
FENOFIBRATE 75 65 45 90
ZETIA 74 69 47 89
CEFDINIR 72 62 48 185
GUANFACINE HCL 72 72 R 48 250
NAPROXEN 71 64 50 71
EVISTA 69 69 51 119
NAMENDA 66 66 52 35
CITALOPRAM HBR 66 66 52 17
ATORVASTATIN CALCIUM 66 59 52 20
LANTUS 65 56 55 55
CIPROFLOXACIN HCL 65 62 55 45
PROPRANOLOL HCL 64 64 57 120
VERAPAMIL ER 64 64 57 101
SPIRONOLACTONE 62 46 59 62
IRBESARTAN 60 60 60 284
PROAIR HFA 59 50 61 79
ENALAPRIL MALEATE 58 47 62 65
TRIAMTERENE-HCTZ 56 56 63 43
GEMFIBROZIL 54 50 64 137
BENAZEPRIL HCL 54 48 64 58
DILTIAZEM 24HR CD 54 47 64 152
TRAMADOL HCL 54 51 64 19
ESCITALOPRAM OXALATE 53 42 68 73
KLOR-CON 10 52 34 69 95
BACLOFEN 50 43 70 144
BENICAR 50 41 70 218
LEVOFLOXACIN 50 46 70 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.